Thomas J. Garrity, Director at ANTARES PHARMA, INC. (ATRS), sold 50,000 shares at $4.28 ($214K) on 2021-03-11, disclosed to the SEC on 2021-03-12.
Open-market sale of $214k ATRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATRS | SELL | 2019-12-11 | $183K | — | Filing → |
| ATRS | SELL | 2019-05-03 | $80K | — | Filing → |
| ATRS | SELL | 2017-10-05 | $105K | — | Filing → |